← SynDRA
ADEFOVIR
SynDRA canonical compound SYN0000394 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | DNA polymerase inhibitor |
| Indication | hepatitis B |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- DNA polymerase inhibitor
- Inhibitor
Cross-references
Synonyms
- GS-0393
- GS0393
- PMEA
- ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid
- 9-(2-Phosphonylmethoxyethyl)adenine
- GS 0393
- GS 393
- 9-(2-(Phosphonomethoxy)ethyl)adenine
- N-(2-Phosphonylmethoxyethyl)adenine
- DRG-0156
- UNII-6GQP90I798
- C8H12N5O4P
- HSDB 8079
- CHEMBL484
- 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid
- BRN 3561094
- {[2-(6-Amino-9h-Purin-9-Yl)ethoxy]methyl}phosphonic Acid
- N-(2-Phophonomethoxyethyl-2,6-diaminopurine)
- Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-
- 6GQP90I798
- Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)-
- 9-(2-phosphonomethoxyethyl)adenine
- 9-[2-(phosphonomethoxy)ethyl]adenine
- CHEBI:2469
- DTXCID4026214
- [[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic Acid
- 9-[2-phosphonomethoxyethyl]adenine
- 9-PMEA
- Adefovirum
- Phosphonylmethoxyethyl-a
- RefChem:56259
- J05AF08
- MFCD00866943
- (2-(6-amino-9H-purin-9-yl)ethoxy)methylphosphonic acid
- [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid
- NCGC00160539-01
- Adefovir [USAN:INN:BAN]
- SUPKOOSCJHTBAH-UHFFFAOYSA-N
Reported adverse events
- Lactic acidosis
- HIV infection
- Lactic acid
- Fanconi syndrome
- Headache
- Asthenia
- Dyspepsia
- Flatulence
- Hepatitis
- Nausea
Look up ADEFOVIR in the interactive SynDRA portal →